Related Experiment Video
Updated: Jun 13, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary
Peila Chen1, Jamye F O'Neal, Nancy D Ebelt
1Division of Pharmacology and Toxicology, Center for Molecular and Cellular Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, United States of America.
Abstract:
Oncogenes induce cell proliferation leading to replicative stress, DNA damage and genomic instability. A wide variety of cellular stresses activate c-Jun N-terminal kinase (JNK) proteins, but few studies have directly addressed the roles of JNK isoforms in tumor development. Herein, we show that jnk2 knockout mice expressing the Polyoma Middle T Antigen transgene developed mammary tumors earlier and experienced higher tumor multiplicity compared to jnk2 wildtype mice. Lack of jnk2 expression was associated with higher tumor aneuploidy and reduced DNA damage response, as marked by fewer pH2AX and 53BP1 nuclear foci. Comparative genomic hybridization further confirmed increased genomic instability in PyV MT/jnk2-/- tumors. In vitro, PyV MT/jnk2-/- cells underwent replicative stress and cell death as evidenced by lower BrdU incorporation, and sustained chromatin licensing and DNA replication factor 1 (CDT1) and p21(Waf1) protein expression, and phosphorylation of Chk1 after serum stimulation, but this response was not associated with phosphorylation of p53 Ser15. Adenoviral overexpression of CDT1 led to similar differences between jnk2 wildtype and knockout cells. In normal mammary cells undergoing UV induced single stranded DNA breaks, JNK2 localized to RPA (Replication Protein A) coated strands indicating that JNK2 responds early to single stranded DNA damage and is critical for subsequent recruitment of DNA repair proteins. Together, these data support that JNK2 prevents replicative stress by coordinating cell cycle progression and DNA damage repair mechanisms.
Insights
JNK2 deficiency accelerates mammary tumor development and increases genomic instability in mice. JNK2 is crucial for DNA damage response and preventing replicative stress.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Oncogenes drive cell proliferation, leading to replicative stress, DNA damage, and genomic instability.
- c-Jun N-terminal kinase (JNK) proteins are activated by cellular stress, but JNK isoform roles in tumor development are understudied.
Purpose of the Study:
- To investigate the role of JNK2 in mammary tumor development and genomic stability.
- To elucidate the mechanisms by which JNK2 influences DNA damage response and cell cycle progression.
Main Methods:
- Utilized jnk2 knockout and wildtype mice expressing the Polyoma Middle T Antigen (PyV MT) transgene.
- Assessed tumor development, multiplicity, aneuploidy, and DNA damage response markers (pH2AX, 53BP1 foci).
- Performed comparative genomic hybridization (CGH) and in vitro cell-based assays (BrdU incorporation, protein expression analysis, RPA localization).
Main Results:
- jnk2 knockout mice exhibited earlier mammary tumor onset and higher tumor multiplicity compared to wildtype controls.
- Loss of JNK2 was associated with increased tumor aneuploidy, reduced DNA damage response, and heightened genomic instability.
- In vitro studies showed jnk2 deficiency impaired response to replicative stress and DNA damage, affecting cell cycle regulators.
Conclusions:
- JNK2 plays a critical role in preventing mammary tumor development and maintaining genomic stability.
- JNK2 is essential for coordinating cell cycle progression and DNA damage repair mechanisms in response to stress.
- JNK2 acts early in the DNA damage response pathway, facilitating the recruitment of repair proteins.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
05:06Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector
Published on: February 2, 2021
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Mutagenicity and Carcinogenicity
Induced Pluripotent Stem Cells
Somatic cells are...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...